JANUS HENDERSON GROUP PLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$539,434
-56.2%
26,199
+0.0%
0.00%
-100.0%
Q2 2023$1,231,300
-93.0%
26,195
-93.7%
0.00%
-91.7%
Q1 2023$17,570,568
-25.6%
418,746
-32.4%
0.01%
-29.4%
Q4 2022$23,619,462
-17.6%
619,290
-57.7%
0.02%
-19.0%
Q3 2022$28,671,643
+15.7%
1,462,846
+90.7%
0.02%
+23.5%
Q2 2022$24,776,000
-27.3%
767,049
-25.5%
0.02%
+6.2%
Q1 2022$34,092,000
-17.8%
1,029,953
+5.6%
0.02%
-5.9%
Q4 2021$41,476,000
-10.9%
974,982
-7.2%
0.02%
-15.0%
Q3 2021$46,569,000
-50.6%
1,050,993
-36.7%
0.02%
-50.0%
Q2 2021$94,330,000
-32.7%
1,660,453
-11.4%
0.04%
-37.5%
Q1 2021$140,226,000
-18.1%
1,873,382
-5.3%
0.06%
-20.0%
Q4 2020$171,190,000
+72.9%
1,978,811
+22.2%
0.08%
+53.8%
Q3 2020$98,995,000
+63.1%
1,619,701
+11.0%
0.05%
+52.9%
Q2 2020$60,695,000
+52.3%
1,459,676
+5.2%
0.03%
+25.9%
Q1 2020$39,857,000
-77.1%
1,387,795
-42.5%
0.03%
-69.7%
Q4 2019$174,282,000
-38.4%
2,414,212
+19.8%
0.09%
-41.8%
Q3 2019$282,741,000
-17.6%
2,015,404
+7.6%
0.15%
-17.7%
Q2 2019$343,002,000
+29.2%
1,873,408
+12.3%
0.19%
+26.5%
Q1 2019$265,395,000
+797.5%
1,668,629
+440.6%
0.15%
+673.7%
Q4 2018$29,569,000
-20.9%
308,682
+16.6%
0.02%
-5.0%
Q3 2018$37,384,000
+34.8%
264,663
+49.3%
0.02%
+25.0%
Q2 2018$27,743,000
-6.7%
177,236
-4.0%
0.02%
-11.1%
Q1 2018$29,741,000
-8.4%
184,649
-6.3%
0.02%
-10.0%
Q4 2017$32,454,000197,0350.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders